Current Portfolio
EQT invests in good companies with a mission to help them develop into great companies.
EQT invests in good companies with a mission to help them develop into great companies.
Company | Sector | Fund | Market | Entry |
|---|---|---|---|---|
| ONWARD | Life Sciences | LSP 5 | Netherlands | 2016 |
| Orphazyme | Life Sciences | LSP 5 | Denmark | 2017 |
| OxThera | Life Sciences | LSP 5 | Sweden | 2016 |
| Pantera | Life Sciences | LSP 7 | Belgium | 2024 |
| Perfuze | Life Sciences | LSP HEF 2 | Ireland | 2022 |
| Phagenesis | Life Sciences | EQT HE 3 | United Kingdom | 2024 |
| Pharvaris | Life Sciences | LSP 5 | Germany | 2016 |
| QurAlis | Life Sciences | LSP Dementia Fund | United States | 2022 |
| Sequana Medical | Life Sciences | LSP HEF 1 | Belgium | 2024 |
| Sequana Medical | Life Sciences | EQT HE 3 | Belgium | 2024 |
| Shinobi Therapeutics | Life Sciences | LSP 7 | United States | 2023 |
| SNIPR Biome | Life Sciences | LSP 6 | Denmark | 2019 |
| SpliceBio | Life Sciences | LSP 7 | Spain | 2025 |
| T-Knife | Life Sciences | LSP 6 | Germany | 2021 |
| Tenpoint Therapeutics | Life Sciences | LSP 6 | United States | 2021 |
| Tubulis | Life Sciences | LSP 7 | Germany | 2024 |
| VarmX | Life Sciences | LSP 6 | Netherlands | 2020 |
| VectorY | Life Sciences | LSP Dementia Fund | Netherlands | 2023 |
| ViCentra | Life Sciences | LSP 5 | Netherlands | 2016 |
| ViCentra | Life Sciences | LSP HEF 2 | Netherlands | 2016 |
| ViCentra | Life Sciences | LSP HEF 1 | Netherlands | 2016 |
| Vico Therapeutics | Life Sciences | LSP 6 | Belgium | 2019 |
| Vivasure | Life Sciences | LSP HEF 1 | Ireland | 2016 |
| Xeltis | Life Sciences | LSP HEF 2 | Netherlands | 2014 |
| Xeltis | Life Sciences | LSP HEF 1 | Netherlands | 2014 |